BEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTE CO LTD has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), China and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are HONG GUAN LTD, BENITEC AUSTRALIA LTD and MPB COLOGNE GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | China | 3 | |
#3 | United States | 3 | |
#4 | Canada | 1 | |
#5 | Republic of Korea | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Medical technology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Animal care | |
#5 | Peptides | |
#6 | Enzymes | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Deng Hongkui | 12 |
#2 | Li Xiang | 5 |
#3 | Liu Bei | 4 |
#4 | Du Xiaomin | 4 |
#5 | Liu Defang | 4 |
#6 | Ma Yantao | 4 |
#7 | Yang Yang | 4 |
#8 | Xu Jun | 4 |
#9 | Zhao Ting | 3 |
#10 | Ye Junqing | 3 |
Publication | Filing date | Title |
---|---|---|
US2020277567A1 | Methods for chemically induced lineage reprogramming | |
CN106967686A | Method and human tissue the engineering regeneration of cartilage of the external lengthening of telomeres Multiplying culture of cartilage cell | |
KR20180052612A | Induced pluripotent stem cells, methods for their production and use | |
EP3384007A1 | Improved methods for reprograming non-pluripotent cells into pluripotent stem cells |